Concepedia

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7

Katsuyuki Adachi, Kei Kawana, Terufumi Yokoyama, Tomoyuki Fujii, Ayako Tomio, Shiho Miura, Kensuke Tomio, Satoko Kojima, Katsutoshi Oda, Tomomitsu Sewaki,

Vaccine · 2010 · 99 citations · 40 references

DOI

Concepts

References

40

Cancer incidence, mortality and prevalence worldwide

J Ferlay · Medical Entomology and Zoology · 2004 · 3.8K citations

, , +13

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

F. Xavier Bosch, M. Michele Manos, Mark E. Sherman et al. · JNCI Journal of the National Cancer Institute · 1995 · 3.4K citations

, , +17

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

K Y Lin, Frank Guarnieri, Kevin F. Staveley-O’Carroll et al. · PubMed · 1996 · 1K citations

, , +17

Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

Mariet C.W. Feltkamp, Henk L. Smits, Michel Vierboom et al. · European Journal of Immunology · 1993 · 838 citations

, , +17

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

Gloria Y. F. Ho, Robert D. Burk, S. Klein et al. · JNCI Journal of the National Cancer Institute · 1995 · 818 citations

, , +17